The Effect of a Multicomponent Intervention on Quality of Life in Residents of Nursing Homes: A Randomized Controlled Trial (COSMOS).

Multicomponent intervention activity advance care planning dementia implementation medication review neuropsychiatric symptoms nursing home pain assessment pain treatment quality of life

Journal

Journal of the American Medical Directors Association
ISSN: 1538-9375
Titre abrégé: J Am Med Dir Assoc
Pays: United States
ID NLM: 100893243

Informations de publication

Date de publication:
03 2019
Historique:
received: 26 03 2018
revised: 02 11 2018
accepted: 06 11 2018
pubmed: 12 1 2019
medline: 19 8 2020
entrez: 12 1 2019
Statut: ppublish

Résumé

To investigate if the multicomponent intervention of the COSMOS trial, combining communication, systematic pain management, medication review, and activities, improved quality of life (QoL) in nursing home patients with complex needs. Multicenter, cluster-randomized, single-blinded, controlled trial. Thirty-three nursing homes with 67 units (clusters) from 8 Norwegian municipalities. Seven hundred twenty-three patients with and without dementia (≥65 years) were cluster randomized to usual care or intervention in which health care staff received standardized education and on-site training for 4 months with follow-up at month 9. Primary outcome was change in QoL as measured by QUALIDEM (QoL dementia scale); QUALID (QoL late-stage dementia scale), and EQ-VAS (European QoL-visual analog scale) from baseline to month 4. Secondary outcomes were activities of daily living (ADL), total medication, staff distress, and clinical global impressions of change (CGIC). During the active intervention, all 3 QoL measures worsened, 2 significantly (QUALID P = .04; QUALIDEM P = .002). However, follow-up analysis from month 4 to 9 showed an intervention effect for EQ-VAS (P = .003) and QUALIDEM total score (P = .01; care relationship P = .02; positive affect P = .04, social relations P = .01). The secondary outcomes of ADL function, reduction of medication (including psychotropics) and staff distress, improved significantly from baseline to month 4. Intervention effects were also demonstrated for CGIC at month 4 (P = .023) and 9 (P = .009), mainly because of deterioration in the control group. Temporarily, the QoL decreased in the intervention group, leading to our hypothesis that health care staff may be overwhelmed by the work-intensive COSMOS intervention period. However, the decrease reversed significantly during follow-up, indicating a potential learning effect. Further, the intervention group improved in ADL function and received less medication, and staff reported less distress and judged COSMOS as able to bring about clinically relevant change. This suggests that nonpharmacologic multicomponent interventions require long follow-up to ensure uptake and beneficial effects.

Identifiants

pubmed: 30630722
pii: S1525-8610(18)30638-8
doi: 10.1016/j.jamda.2018.11.006
pii:
doi:

Types de publication

Journal Article Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

330-339

Informations de copyright

Copyright © 2018 AMDA – The Society for Post-Acute and Long-Term Care Medicine. All rights reserved.

Auteurs

Bettina S Husebø (BS)

Department of Global Public Health and Primary Care, Centre for Elderly and Nursing Home Medicine, Faculty of Medicine, University of Bergen, Norway; Municipality of Bergen, Bergen, Norway. Electronic address: Bettina.Husebo@uib.no.

Clive Ballard (C)

University of Exeter Medical School, Exeter, United Kingdom; Centre for Age-Related Medicine, Stavanger University Hospital, Stavanger, Norway.

Dag Aarsland (D)

Centre for Age-Related Medicine, Stavanger University Hospital, Stavanger, Norway; Kings College, Institute of Psychiatry, Psychology and Neuroscience, London, United Kingdom.

Geir Selbaek (G)

National Advisory Unit of Ageing and Health, Vestfold Hospital Trust, Tonsberg, Norway; Centre for Old Age Psychiatry Research, Innlandet Hospital Trust, Ottestad, Norway.

Dagrun D Slettebo (DD)

Department of Global Public Health and Primary Care, Centre for Elderly and Nursing Home Medicine, Faculty of Medicine, University of Bergen, Norway.

Christine Gulla (C)

Department of Global Public Health and Primary Care, Centre for Elderly and Nursing Home Medicine, Faculty of Medicine, University of Bergen, Norway.

Irene Aasmul (I)

Department of Global Public Health and Primary Care, Centre for Elderly and Nursing Home Medicine, Faculty of Medicine, University of Bergen, Norway.

Torstein Habiger (T)

Department of Global Public Health and Primary Care, Centre for Elderly and Nursing Home Medicine, Faculty of Medicine, University of Bergen, Norway.

Tony Elvegaard (T)

Department of Global Public Health and Primary Care, Centre for Elderly and Nursing Home Medicine, Faculty of Medicine, University of Bergen, Norway.

Ingelin Testad (I)

Centre for Age-Related Medicine, Stavanger University Hospital, Stavanger, Norway; University of Exeter Medical School, Exeter, United Kingdom.

Elisabeth Flo (E)

Department of Global Public Health and Primary Care, Centre for Elderly and Nursing Home Medicine, Faculty of Medicine, University of Bergen, Norway; Faculty of Psychology, University of Bergen, Norway.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH